Dublin, Ohio-based Cardinal Health has agreed to pay $8 million to resolve claims that it made payments to induce referral orders for its prescription drugs, according to a Department of Justice news release.
The case alleged that Cardinal Health violated the False Claims Act and Anti-Kickback Statute. It was filed by two whistleblowers: pharmacy owner R. Daniel Saleaumua and pharmacy consultant Kevin Rinne. Mr. Saleaumua alleged that Cardinal paid him $440,000 in exchange for purchasing Cardinal drugs.
Together, Mr. Saleaumua and Mr. Rinne will receive $760,000 of the settlement.
Read the DOJ release on Cardinal Health’s settlement.
Read about other pharmaceutical companies involved in lawsuits:
– CVS Pays $17M To Settle Medicaid Fraud Allegations
– Harvard Drug Group Pays $8M to Settle Claims of Failure to Report Suspicious Drug Orders
– Bristol-Myers Accused of Kickbacks, Bribing Physicians With Gifts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
